Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

@article{Chabannon2003CosteffectivenessOR,
  title={Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation},
  author={Christian Chabannon and A-G Le Corroller and Fr{\'e}d{\'e}ric Viret and C Eillen and Catherine Faucher and J P Moatti and Patrice Viens and Norbert Vey and A C Braud and Gis{\`e}le Novakovitch and Patrick Ladaique and A M Stoppa and Jacques Camerlo and Dominique Genre and Dominique Maraninchi and Didier Blaise},
  journal={Leukemia},
  year={2003},
  volume={17},
  pages={811-813}
}
We retrospectively analyzed a cohort of 435 patients who – from 1992 to 1998 – received high-dose chemotherapy and autologous blood cell transplantation for a variety of nonleukemic malignancies at a single institution. Autologous cells and progenitors were mobilized in the blood, with daily administration of rhG-CSF (Filgrastim, Amgen, Thousand Oaks, CA, USA): 600 mg per day SQ, or after administration of various chemotherapy regimens, followed by the daily administration of rhG-CSF, 300 mg… CONTINUE READING
10 Extracted Citations
8 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 10 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-8 of 8 references

primed blood cells (BC) and bone marrow (BM) allogeneic transplantation

  • AL Pecora, P Stiff, CF LeMaistre, R Bayer, C Bachier, SL Goldberg
  • Bone Marrow Transplant
  • 1998

Similar Papers

Loading similar papers…